Cargando…
The co-inhibitory immune checkpoint proteins B7-H1(PD-L1) and B7-H4 in high grade glioma: From bench to bedside
Co-inhibitory immune checkpoints play a crucial role in tumor progression, and PD-1/PD-L1 inhibitor has been a breakthrough for treating multiple refractory tumors in last decade. Nevertheless, results of several phase III clinical trials of PD-1/PD-L1 inhibitor are unsatisfactory in high grade glio...
Autores principales: | Qi, Ying, Huang, Xiaoming, Ji, Chunxia, Wang, Chaojun, Yao, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587763/ https://www.ncbi.nlm.nih.gov/pubmed/37844479 http://dx.doi.org/10.1016/j.tranon.2023.101793 |
Ejemplares similares
-
B7x—from bench to bedside
por: Kaur, Gurbakhash, et al.
Publicado: (2019) -
B7-H3 and B7-H1 expression in cerebral spinal fluid and tumor tissue correlates with the malignancy grade of glioma patients
por: BARAL, APARAJITA, et al.
Publicado: (2014) -
Gene therapies for high-grade gliomas: from the bench to the bedside
por: Giotta Lucifero, Alice, et al.
Publicado: (2020) -
Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors
por: Chen, Di, et al.
Publicado: (2020) -
Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma
por: Wang, Yuelong, et al.
Publicado: (2020)